药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sinecatechins
Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Bamet-UD2.
Sinecatechins
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Bamet-UD2.
Sinecatechins
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Bamet-UD2.
Sinecatechins
Nitroaspirin
The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Bamet-UD2.
Sinecatechins
Ifetroban
The risk or severity of adverse effects can be increased when Ifetroban is combined with Bamet-UD2.
Sinecatechins
Sarpogrelate
The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Bamet-UD2.
Sinecatechins
Naftopidil
The risk or severity of adverse effects can be increased when Naftopidil is combined with Bamet-UD2.
Sinecatechins
Trapidil
The risk or severity of adverse effects can be increased when Trapidil is combined with Bamet-UD2.
Sinecatechins
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Bamet-UD2.
Sinecatechins
Icosapent ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Bamet-UD2.
Sinecatechins
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Bamet-UD2.
Sinecatechins
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Bamet-UD2.
Sinecatechins
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Bamet-UD2.
Sinecatechins
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Bamet-UD2.
Sinecatechins
Caplacizumab
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Bamet-UD2.
Sinecatechins
Andrographolide
The risk or severity of adverse effects can be increased when Andrographolide is combined with Bamet-UD2.
Sinecatechins
Ibudilast
The risk or severity of adverse effects can be increased when Ibudilast is combined with Bamet-UD2.
Sinecatechins
Beraprost
The risk or severity of adverse effects can be increased when Beraprost is combined with Bamet-UD2.
Sinecatechins
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Bamet-UD2.
Sinecatechins
Tesmilifene
The risk or severity of adverse effects can be increased when Tesmilifene is combined with Bamet-UD2.